Biallelic GLDN mutations have recently been identified among infants with lethal congenital contracture syndrome 11 (LCCS11). GLDN encodes gliomedin, a protein required for the formation of the nodes of Ranvier and development of the human peripheral nervous system. We report six infants and children from four unrelated families with biallelic GLDN mutations, four of whom survived beyond the neonatal period into infancy, childhood, and late adolescence with intensive care and chronic respiratory and nutritional support. Our findings expand the genotypic and phenotypic spectrum of LCCS11 and demonstrate that the condition may not necessarily be lethal in the neonatal period.
Arthrogryposis multiplex congenita (AMC) is a disorder characterized by multiple joint contractures (limbs, jaw, spine) and limited movements at birth. AMC results from diverse mechanisms, including virtually any condition that decreases or limits fetal movements. AMC is present in 1/4300 births (Lowry, Sibbald, Bedard, & Hall, 2010) and can be associated with craniofacial abnormalities, pulmonary hypoplasia, shortened umbilical cord, and/or polyhydramnios (Hall, 2009) . Severity of the AMC phenotype is heterogeneous ranging from limited limb involvement to more extensive neurologic deficits including central nervous system impairment. AMC has been associated with chromosomal abnormalities (Reed, Hall, Riccardi, Aylsworth, & Timmons, 1985) , mitochondrial disorders (von Kleist-Retzow et al., 2003) , and sporadic and inherited mutations in more than 220 genes, including genes that regulate central nervous system development (neuronal axonogenesis, Schwann and glial cell development), skeletal muscle, synaptic transmission, and glycoprotein metabolism (Bayram et al., 2016; Hall & Kiefer, 2016; Narkis, Landau, Manor, Ofir, & Birk, 2007) . Recently, the first association of biallelic GLDN (MIM# 608603) mutations with a lethal form of AMC (LCCS11; MIM# 617194) was reported in four unrelated families (Maluenda et al., 2016) . Here, we report six additional infants and children from four unrelated families with AMC and biallelic GLDN mutations. Four of the affected infants survived beyond the neonatal period with intensive care, chronic ventilatory and nutritional support, and rehabilitation therapy. Our findings confirm the association of GLDN mutations with AMC and extend the LCCS11 phenotype by describing long-term survival with chronic respiratory and nutritional support.
PATIENTS AND EXOME SEQUENCING
The parents/caregivers of all infants and children provided informed consent for participation. These studies were reviewed and approved by the Institutional Review Boards at each university. Sanger sequencing was used to confirm putative variants identified by exome sequencing. We used Genematcher (Sobreira, Schiettecatte, Valle, & Hamosh, 2015) to identify additional investigators with interest in GLDN. Variants were annotated in GenBank RefSeq transcript NM_181789.2, and were submitted to the Leiden Open Variation Database 3.0 at http://www.lovd.nl/GLDN.
Family1
After clinical exome sequencing of peripheral blood-derived DNA from the affected daughter and both parents using the Agilent Clinical Exome kit did not identify pathogenic variants, we performed research analysis of available variant call format (VCF) and BAM files. Specifically, variants were annotated with ANNOVAR (version (ver) 2015Dec14) http://annovar.openbioinformatics.org/en/latest/) (Wang, Li, & Hakonarson, 2010 ) and pathogenicity of novel or rare (minor allele frequency < 0.01 in the Exome Aggregation Consortium (ExAC) database (exac.broadinstitute.org) (Lek et al., 2016) coding region variants was predicted using functional programs in dbNSFP (ver 3.3a, https://sites.google.com/site/jpopgen/dbNSFP) (Liu, Jian, & Boerwinkle, 2011; Liu, Wu, Li, & Boerwinkle, 2016) . Pathogenicity of variants in splicing consensus regions was assessed using the dbscSNV database (Liu et al., 2016) . Candidate genes were reviewed manually for possible associations with the infant's phenotype.
Family 2
Exome sequencing of DNA isolated from peripheral blood of the affected child was performed as described previously (Kremer et al., 2016) using the SureSelect Human All Exon V5 kit (Agilent, Santa Clara, California). Reads were aligned to GRCh37/hg19 using the BurrowsWheeler Aligner (ver 0.7.5 a) (Li & Durbin, 2009 ). Single-nucleotide variants and small insertions and deletions (indels) were detected with SAMtools (ver 0.1.19) ).
Family 3
Targeted capture of coding regions (Illumina, San Diego, California, TruSight One panel) was performed on DNA isolated from the affected fetus. Reads were aligned to GRCh37/hg19 using the BurrowsWheeler Aligner (ver 0.7.5 a) (Li & Durbin, 2009 ). Variants were called using GATK (DePristo et al., 2011) and annotated using vtools (San Lucas, Wang, Scheet, & Peng, 2012) and ANNOVAR (Wang et al., 2010) .
Variant pathogenicity was predicted using dbNSFP (Liu, Jian, & Boerwinkle, 2013 ). Arthrogryposis and contractural syndrome genes were analyzed in a targeted manner but were nondiagnostic. Homozygosity mapping (www.homozygositymapper.com) of the exome sequencing data revealed a segment of homozygosity on chromosome 15. Given the familial recurrence and suspicion for an autosomal-recessive disorder, whole-exome sequencing (Illumina Nextera Coding Exome) was performed on DNA samples from the affected fetus, affected living child, and parents.
Family 4
Exome sequencing of the second affected child and parents and variant annotation were performed as described previously (Bahamonde et al., 2015) using whole-exome capture (Nimblegene SeqCap EZ Human Exome version 3). Variants were annotated using ANNOVAR (Wang et al., 2010) and an in-house annotation database. Variants in coding regions (nonsense, missense, frameshift, and in-frame insertions or deletions) and near exon-intron junctions were prioritized using both functional annotations (e.g., population allele frequency, predicted pathogenicity, and conservation) and possible modes of inheritance (recessive, compound heterozygous, X-linked, and dominant de novo) with the eDiVA pipeline (ver 1.0, http://ediva.crg.es).
CLINICAL FINDINGS

Family 1
Three affected infants were consecutively born to unrelated, healthy, European-descent parents. The pregnancy of the first infant was TA B L E 1 Clinical characteristics of infants and children with biallelic GLDN variants and arthrogryposis multiplex congenita (Table 1) . He was extubated to CPAP on the 2nd day of life, but persistent respiratory failure prompted tracheostomy at 2 months of age. He is currently ventilator dependent at 7 months of age and has a gastrostomy tube for nutritional supplementation.
Family 2
A male infant was born at 32 weeks gestation to parents of EastEuropean Roma origin (birth weight 1,780 g [50 th percentile]) and has lived with a foster family since 6 years of age. Information about his disease course, neurocognitive development during the 1st years of life, and family history including consanguinity is limited (Table 1) . Pregnancy was complicated by polyhydramnios, and he was delivered by cesarean section due to nonreassuring fetal surveillance. He required resuscitation, intubation, and ventilation immediately after birth due to respiratory failure. Physical examination was consistent with AMC (Table 1) . Due to persistent respiratory insufficiency associated with pulmonary hypoplasia and diaphragm paralysis, he underwent tracheostomy at 3 months of age.
He underwent surgical treatment for bilateral hip luxation and clubfeet (age 2 years) and scoliosis with Harrington rod insertion (age 9 years). Over his 1st decade of life, he successfully weaned from respiratory support including tracheostomy decannulation at 7 years of age. By 12 years of age, he was independent in his daily life activities, fully ambulant, able to dress himself, and ride a bicycle over more than 10 km. His neurologic examination was notable for myopathic facies, very weak to absent deep tendon reflexes, and symmetric atrophy and weakness of his proximal muscles. 
Family 3
After the birth of two unaffected females to healthy, unrelated parents of East European descent, a third pregnancy was complicated by reduced fetal movements, multiple contractures, narrow thorax, polyhydramnios, and skin edema first noticed at 30 weeks of gestation, and pregnancy was terminated at 31 weeks. Physical examination of the female fetus (body weight 1,770 g [80 th percentile]) was consistent with AMC (Table 1) . Autopsy information is not available for this fetus.
The fourth child (male) was born at 41 weeks gestation by vaginal delivery after a reportedly normal pregnancy (birth weight 3,560 g
[30 th percentile]). Due to respiratory distress at birth, the infant was intubated and mechanically ventilated. His physical examination at birth was consistent with AMC (Table 1) . Due to persistent respiratory insufficiency, inability to cough, and insufficient swallowing, he underwent tracheostomy at 6 weeks of age. His respiratory function gradually improved, and he was successfully weaned from ventilatory support at 9 months of age and subsequently decannulated at 19 months of age. Physiotherapy and nonsurgical treatment including splinting led to an improvement of his contractures, increased range of motion, and improved muscular tone in his lower limbs. Distal muscular atrophy developed over time. Motor and language development was delayed;
he was able to sit independently at the age of 13 months and started to crawl at the age of 24 months. At the age of 28 months, he uses five words, and understands and follows simple commands. Insufficient swallowing aggravated by paresis of both the right vocal cord and right side of the soft palate prompted gastrostomy tube placement at 4 months of age. Oral feedings were initiated at 1 year of age and continue at the age of 28 months with most of his feedings by mouth and nutritional supplementation via gastrostomy tube. His clinical course was also notable for orchidopexy at 5 months of age and a febrile seizure at 26 months of age. Nerve conduction velocity studies performed at 1 week of age demonstrated axonal motor and sensory neuropathy but were normal when repeated at 7 months of age. Electromyography did not show any pathological finding. Muscle biopsy and MRI of the brain and spinal cord were normal.
Family 4
After the birth of an unaffected son to healthy, unrelated parents of (Table 1) . A subsequent pregnancy was notable for polyhydramnios and antenatal ultrasound findings of arthrogryposis and pulmonary hypoplasia at 26 weeks gestation. Fetal MRI performed at 32 weeks showed normal brain and spinal cord images. The female infant was born at 37 weeks gestation and died at 12 hr of age due to respiratory failure. Her physical examination was consistent with AMC (Table 1) . Anatomical examination of the brain and spinal cord revealed edematous and friable tissue, but no obvious macroscopic or histopathologic abnormalities.
EXOME SEQUENCING RESULTS
In Family 1, all three affected infants had biallelic, novel GLDN mutations: a heterozygous frameshift deletion (c.927_930del) that results in a premature stop codon (p.Asn309Lysfs*5) and a pathogenic missense mutation c.1436G> C, p.Arg479Pro (CADD [Kircher et al., 2014] score of 24, predicted damaging by majority of in silico functional prediction programs in ANNOVAR) (Table 1 ; Supp. Fig. S1 ).
In Family 2, the affected male infant was homozygous for (Wang et al., 2010) described above is 1.4% among non-Finnish European-descent individuals and 1.0% among African-descent individuals, suggesting the incidence of AMC related to GLDN variants could be 2-5/100,000 births.
Homozygous gldn −/− mice do not have apparent neurologic deficits or features of arthrogryposis and demonstrate normal nerve conduction and peripheral nervous system myelin (Feinberg et al., 2010) .
However, the Schwann cell microvilli from these mice appear disorganized with abnormal orientation to the axolemma, and the sciatic nerves lack sodium channel clustering at the heminodes (Feinberg et al., 2010). Antibodies to gliomedin and neurofascin have been identified among patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy, suggesting the node of Ranvier is the primary immunologic target (Devaux, 2012) . Both active and passive immunity to gliomedin results in a progressive neuropathy among Lewis rats characterized by decreased nerve conduction velocity, nodal elongation, paranodal demyelination, and disruption of sodium channel clustering (Devaux, 2012) . Spinal root ultrastructure of the first male infant of Family 1 demonstrates lengthening of the node of Ranvier (Fig. 1A) , similar to a previous report of an infant with recessive GLDN mutations (Maluenda et al., 2016) . Muscle biopsy from the female infant in Family 1 demonstrates muscle fibers of varied sizes including some with central nuclei and type II muscle fiber predominance with excessive numbers of immature type IIC muscle fibers ( Fig. 1C-E) . The difference between murine gldn -/-and human GLDN biallelic mutation phenotypes may be attributable to differences between genetic abrogation of GLDN expression and expression of abnormal gliomedin protein.
Of the six previously reported infants with biallelic GLDN mutations and AMC, two live-born infants died within the first day of life likely due to pulmonary insufficiency (Maluenda et al., 2016) . Survival of four infants in our series (currently at ages 7 months, 22 months, 28 months, and 17 years) suggests that pulmonary insufficiency in patients with AMC due to biallelic GLDN mutations may not necessarily be life 
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